Skip to main content
Top
Published in: BMC Nephrology 1/2011

Open Access 01-12-2011 | Research article

Survival in dialysis patients is not different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition

Authors: Marielle A Schroijen, Olaf M Dekkers, Diana C Grootendorst, Marlies Noordzij, Johannes A Romijn, Raymond T Krediet, Elisabeth W Boeschoten, Friedo W Dekker, the NECOSAD Study Group

Published in: BMC Nephrology | Issue 1/2011

Login to get access

Abstract

Background

On dialysis, survival among patients with diabetes mellitus is inferior to survival of non-diabetic patients. We hypothesized that patients with diabetes as primary renal disease have worse survival compared to patients with diabetes as a co-morbid condition and aimed to compare all-cause mortality between these patient groups.

Methods

Data were collected from the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD), a multicenter, prospective cohort study in which new patients with end stage renal disease (ESRD) were monitored until transplantation or death. Patients with diabetes as primary cause of ESRD were compared with patients with diabetes as co-morbid condition and both of these patient groups were compared to patients without diabetes. Analysis was performed using Kaplan-Meier and Cox regression.

Results

Fifteen % of the patients had diabetic nephropathy as primary renal disease (N = 281); 6% had diabetes as co-morbid condition (N = 107) and 79% had no diabetes (N = 1465). During follow-up 42% of patients (N = 787) died. Compared to non-diabetic patients, mortality risk was increased for both patients with diabetes as primary renal disease HR: 1.9 (95% CI 1.6, 2.3) and for patients with diabetes as co-morbid condition HR: 1.7 (95% CI 1.3, 2.2). Mortality was not significantly higher in patients with diabetes as primary renal disease compared to patients with diabetes as co-morbid condition (HR 1.06; 95% CI 0.79, 1.43).

Conclusions

This study in patients with ESRD showed no survival difference between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition. Both conditions were associated with increased mortality risk compared to non-diabetic patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Brancati FL, Whelton PK, Randall BL, Neaton JD, Stamler J, Klag MJ: Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial. JAMA. 1997, 278: 2069-2074. 10.1001/jama.1997.03550230045035.CrossRefPubMed Brancati FL, Whelton PK, Randall BL, Neaton JD, Stamler J, Klag MJ: Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial. JAMA. 1997, 278: 2069-2074. 10.1001/jama.1997.03550230045035.CrossRefPubMed
2.
go back to reference Cooper L: USRDS. 2001 Annual Data Report. Nephrol News Issues. 2001, 15: 31, 34-35, 38. Cooper L: USRDS. 2001 Annual Data Report. Nephrol News Issues. 2001, 15: 31, 34-35, 38.
3.
go back to reference Perneger TV, Brancati FL, Whelton PK, Klag MJ: End-stage renal disease attributable to diabetes mellitus. Ann Intern Med. 1994, 121: 912-918.CrossRefPubMed Perneger TV, Brancati FL, Whelton PK, Klag MJ: End-stage renal disease attributable to diabetes mellitus. Ann Intern Med. 1994, 121: 912-918.CrossRefPubMed
4.
go back to reference Lok CE, Oliver MJ, Rothwell DM, Hux JE: The growing volume of diabetes-related dialysis: a population based study. Nephrol Dial Transplant. 2004, 19: 3098-3103. 10.1093/ndt/gfh540.CrossRefPubMed Lok CE, Oliver MJ, Rothwell DM, Hux JE: The growing volume of diabetes-related dialysis: a population based study. Nephrol Dial Transplant. 2004, 19: 3098-3103. 10.1093/ndt/gfh540.CrossRefPubMed
5.
go back to reference Van Dijk PC, Jager KJ, Stengel B, Gronhagen-Riska C, Feest TG, Briggs JD: Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991-2000). Kidney Int. 2005, 67: 1489-1499. 10.1111/j.1523-1755.2005.00227.x.CrossRefPubMed Van Dijk PC, Jager KJ, Stengel B, Gronhagen-Riska C, Feest TG, Briggs JD: Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991-2000). Kidney Int. 2005, 67: 1489-1499. 10.1111/j.1523-1755.2005.00227.x.CrossRefPubMed
6.
go back to reference Vonesh EF, Snyder JJ, Foley RN, Collins AJ: The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int. 2004, 66: 2389-2401. 10.1111/j.1523-1755.2004.66028.x.CrossRefPubMed Vonesh EF, Snyder JJ, Foley RN, Collins AJ: The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int. 2004, 66: 2389-2401. 10.1111/j.1523-1755.2004.66028.x.CrossRefPubMed
7.
go back to reference Sorensen VR, Mathiesen ER, Heaf J, Feldt-Rasmussen B: Improved survival rate in patients with diabetes and end-stage renal disease in Denmark. Diabetologia. 2007, 50: 922-929. 10.1007/s00125-007-0612-5.CrossRefPubMed Sorensen VR, Mathiesen ER, Heaf J, Feldt-Rasmussen B: Improved survival rate in patients with diabetes and end-stage renal disease in Denmark. Diabetologia. 2007, 50: 922-929. 10.1007/s00125-007-0612-5.CrossRefPubMed
8.
go back to reference Villar E, Chang SH, McDonald SP: Incidences, treatments, outcomes, and sex effect on survival in patients with end-stage renal disease by diabetes status in Australia and New Zealand (1991 2005). Diabetes Care. 2007, 30: 3070-3076. 10.2337/dc07-0895.CrossRefPubMed Villar E, Chang SH, McDonald SP: Incidences, treatments, outcomes, and sex effect on survival in patients with end-stage renal disease by diabetes status in Australia and New Zealand (1991 2005). Diabetes Care. 2007, 30: 3070-3076. 10.2337/dc07-0895.CrossRefPubMed
9.
go back to reference Rodriguez JA, Cleries M, Vela E: Diabetic patients on renal replacement therapy: analysis of Catalan Registry data. Renal Registry Committee. Nephrol Dial Transplant. 1997, 12: 2501-2509. 10.1093/ndt/12.12.2501.CrossRefPubMed Rodriguez JA, Cleries M, Vela E: Diabetic patients on renal replacement therapy: analysis of Catalan Registry data. Renal Registry Committee. Nephrol Dial Transplant. 1997, 12: 2501-2509. 10.1093/ndt/12.12.2501.CrossRefPubMed
10.
go back to reference Brunner FP, Brynger H, Challah S, Fassbinder W, Geerlings W, Selwood NH, Tufveson G, Wing AJ: Renal replacement therapy in patients with diabetic nephropathy, 1980-1985. Report from the European Dialysis and Transplant Association Registry. Nephrol Dial Transplant. 1988, 3: 585-595.PubMed Brunner FP, Brynger H, Challah S, Fassbinder W, Geerlings W, Selwood NH, Tufveson G, Wing AJ: Renal replacement therapy in patients with diabetic nephropathy, 1980-1985. Report from the European Dialysis and Transplant Association Registry. Nephrol Dial Transplant. 1988, 3: 585-595.PubMed
11.
go back to reference McMillan MA, Briggs JD, Junor BJ: Outcome of renal replacement treatment in patients with diabetes mellitus. BMJ. 1990, 301: 540-544. 10.1136/bmj.301.6751.540.CrossRefPubMedPubMedCentral McMillan MA, Briggs JD, Junor BJ: Outcome of renal replacement treatment in patients with diabetes mellitus. BMJ. 1990, 301: 540-544. 10.1136/bmj.301.6751.540.CrossRefPubMedPubMedCentral
12.
go back to reference Van Dijk PC, Jager KJ, de Charro F, Collart F, Cornet R, Dekker FW, Grönhagen-Riska C, Kramar R, Leivestad T, Simpson K, Briggs JD: Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries. Nephrol Dial Transplant. 2001, 16: 1120-1129. 10.1093/ndt/16.6.1120.CrossRefPubMed Van Dijk PC, Jager KJ, de Charro F, Collart F, Cornet R, Dekker FW, Grönhagen-Riska C, Kramar R, Leivestad T, Simpson K, Briggs JD: Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries. Nephrol Dial Transplant. 2001, 16: 1120-1129. 10.1093/ndt/16.6.1120.CrossRefPubMed
13.
go back to reference ERA-EDTA Registry: ERA EDTA Registry 2006 Annual report. 2009, Academic Medical Center, Department of Medical Informatics, Amsterdam, The Netherlands, 2008 ERA-EDTA Registry: ERA EDTA Registry 2006 Annual report. 2009, Academic Medical Center, Department of Medical Informatics, Amsterdam, The Netherlands, 2008
14.
go back to reference Jager KJ, Zoccali C, Macleod A, Dekker FW: Confounding: what it is and how to deal with it. Kidney Int. 2008, 73: 256-260. 10.1038/sj.ki.5002650.CrossRefPubMed Jager KJ, Zoccali C, Macleod A, Dekker FW: Confounding: what it is and how to deal with it. Kidney Int. 2008, 73: 256-260. 10.1038/sj.ki.5002650.CrossRefPubMed
15.
go back to reference Catalano C, Postorino M, Marino C: The impact of diabetes on patients' survival in dialysis patients with non-diabetic renal disease and in patients who develop diabetes during chronic dialysis. Nephrol Dial Transplant. 1996, 11: 1124-1128.CrossRefPubMed Catalano C, Postorino M, Marino C: The impact of diabetes on patients' survival in dialysis patients with non-diabetic renal disease and in patients who develop diabetes during chronic dialysis. Nephrol Dial Transplant. 1996, 11: 1124-1128.CrossRefPubMed
16.
go back to reference Liem YS, Wong JB, Hunink MG, de Charro FT, Winkelmayer WC: Comparison of hemodialysis and peritoneal dialysis survival in The Netherlands. Kidney Int. 2007, 71: 153-158. 10.1038/sj.ki.5002014.CrossRefPubMed Liem YS, Wong JB, Hunink MG, de Charro FT, Winkelmayer WC: Comparison of hemodialysis and peritoneal dialysis survival in The Netherlands. Kidney Int. 2007, 71: 153-158. 10.1038/sj.ki.5002014.CrossRefPubMed
17.
go back to reference U.S. Renal Data System, USRDS 2008 Annual Report: 2009, Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2008 U.S. Renal Data System, USRDS 2008 Annual Report: 2009, Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2008
18.
go back to reference Holmes CJ, Shockley TR: Strategies to reduce glucose exposure in peritoneal dialysis patients. Perit Dial Int. 2000, 20 (Suppl 2): S37-S41.PubMed Holmes CJ, Shockley TR: Strategies to reduce glucose exposure in peritoneal dialysis patients. Perit Dial Int. 2000, 20 (Suppl 2): S37-S41.PubMed
19.
go back to reference Marshall J, Jennings P, Scott A, Fluck RJ, McIntyre CW: Glycemic control in diabetic CAPD patients assessed by continuous glucose monitoring system (CGMS). Kidney Int. 2003, 64: 1480-1486. 10.1046/j.1523-1755.2003.00209.x.CrossRefPubMed Marshall J, Jennings P, Scott A, Fluck RJ, McIntyre CW: Glycemic control in diabetic CAPD patients assessed by continuous glucose monitoring system (CGMS). Kidney Int. 2003, 64: 1480-1486. 10.1046/j.1523-1755.2003.00209.x.CrossRefPubMed
20.
go back to reference Friedlander MA, Wu YC, Schulak JA, Monnier VM, Hricik DE: Influence of dialysis modality on plasma and tissue concentrations of pentosidine in patients with end-stage renal disease. Am J Kidney Dis. 1995, 25: 445-451. 10.1016/0272-6386(95)90107-8.CrossRefPubMed Friedlander MA, Wu YC, Schulak JA, Monnier VM, Hricik DE: Influence of dialysis modality on plasma and tissue concentrations of pentosidine in patients with end-stage renal disease. Am J Kidney Dis. 1995, 25: 445-451. 10.1016/0272-6386(95)90107-8.CrossRefPubMed
21.
go back to reference Berrou J, Tostivint I, Verrecchia F, Berthier C, Boulanger E, Mauviel A, Marti HP, Wautier MP, Rondeau E, Hertig A: Advanced glycation end products regulate extracellular matrix protein and protease expression by human glomerular mesangial cells. Int J Mol Med. 2009, 23: 513-520.PubMed Berrou J, Tostivint I, Verrecchia F, Berthier C, Boulanger E, Mauviel A, Marti HP, Wautier MP, Rondeau E, Hertig A: Advanced glycation end products regulate extracellular matrix protein and protease expression by human glomerular mesangial cells. Int J Mol Med. 2009, 23: 513-520.PubMed
22.
go back to reference Kocak H, Gumuslu S, Sahin E, Ceken K, Gocmen YA, Yakupoglu G, Ersoy FF, Tuncer M: Advanced oxidative protein products are independently associated with endothelial function in peritoneal dialysis patients. Nephrology (Carlton). 2009, 14: 273-280. 10.1111/j.1440-1797.2008.01062.x.CrossRef Kocak H, Gumuslu S, Sahin E, Ceken K, Gocmen YA, Yakupoglu G, Ersoy FF, Tuncer M: Advanced oxidative protein products are independently associated with endothelial function in peritoneal dialysis patients. Nephrology (Carlton). 2009, 14: 273-280. 10.1111/j.1440-1797.2008.01062.x.CrossRef
23.
go back to reference Raj DS, Choudhury D, Welbourne TC, Levi M: Advanced glycation end products: a Nephrologist's perspective. Am J Kidney Dis. 2000, 35: 365-380. 10.1016/S0272-6386(00)70189-2.CrossRefPubMed Raj DS, Choudhury D, Welbourne TC, Levi M: Advanced glycation end products: a Nephrologist's perspective. Am J Kidney Dis. 2000, 35: 365-380. 10.1016/S0272-6386(00)70189-2.CrossRefPubMed
Metadata
Title
Survival in dialysis patients is not different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition
Authors
Marielle A Schroijen
Olaf M Dekkers
Diana C Grootendorst
Marlies Noordzij
Johannes A Romijn
Raymond T Krediet
Elisabeth W Boeschoten
Friedo W Dekker
the NECOSAD Study Group
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2011
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-12-69

Other articles of this Issue 1/2011

BMC Nephrology 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.